CastleKnight Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
75,895
-165,002
-68% -$7.85M 0.2% 190
2025
Q4
$9M Sell
240,897
-158,886
-40% -$6.45M 0.51% 65
2025
Q3
$16.2M Sell
399,783
-131,562
-25% -$4.35M 0.87% 44
2025
Q2
$13.6M Buy
531,345
+113,600
+27% +$2.48M 0.9% 41
2025
Q1
$8.92M Buy
417,745
+28,312
+7% +$633K 0.95% 46
2024
Q4
$8.18M Buy
389,433
+22,796
+6% +$527K 0.9% 54
2024
Q3
$8.26M Buy
366,637
+118,000
+47% +$2.28M 0.96% 34
2024
Q2
$4.17M Buy
248,637
+152,300
+158% +$2.45M 0.56% 72
2024
Q1
$1.25M Buy
96,337
+48,500
+101% +$581K 0.18% 178
2023
Q4
$554K Hold
47,837
0.09% 219
2023
Q3
$611K Hold
47,837
0.1% 220
2023
Q2
$655K Buy
47,837
+4,137
+9% +$59.3K 0.13% 190
2023
Q1
$669K Buy
+43,700
New +$668K 0.17% 164

Other funds holding PAHC